Trial intelligence / Profile preview

GnRH Agonist Protocols in ICSI Candidates

NCT05567731Completed

Sponsor
Tanta University
Start
Oct 2022
Primary completion
Dec 2023
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of triptorelin and buserelin in infertility (3 arms), sponsored by Tanta University. Primary endpoint: Ongoing pregnancies. Started Oct 2022; status: completed.

02

Drugs

triptorelinbuserelin
03

Conditions

infertility

Beyond the preview

Go deeper on NCT05567731.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05567731.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call